De Giorgi, Ugo Federico Francesco
 Distribuzione geografica
Continente #
NA - Nord America 189
EU - Europa 159
AS - Asia 109
AF - Africa 7
SA - Sud America 2
Totale 466
Nazione #
US - Stati Uniti d'America 184
CN - Cina 59
IT - Italia 55
IE - Irlanda 28
SG - Singapore 16
FR - Francia 14
SE - Svezia 14
BE - Belgio 11
GB - Regno Unito 9
IN - India 7
NL - Olanda 7
NG - Nigeria 5
CA - Canada 4
DE - Germania 4
IR - Iran 4
JP - Giappone 4
VN - Vietnam 4
ES - Italia 3
PH - Filippine 3
PL - Polonia 3
RU - Federazione Russa 3
TR - Turchia 3
FI - Finlandia 2
IL - Israele 2
KR - Corea 2
UG - Uganda 2
AM - Armenia 1
AR - Argentina 1
BR - Brasile 1
CH - Svizzera 1
HK - Hong Kong 1
HU - Ungheria 1
ID - Indonesia 1
MK - Macedonia 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
RO - Romania 1
TW - Taiwan 1
UA - Ucraina 1
Totale 466
Città #
Chandler 40
Dublin 28
Fairfield 12
Singapore 12
Nyköping 11
Torino 9
Houston 7
Medford 7
Redwood City 7
Shanghai 7
Seattle 6
Turin 6
Ashburn 5
Beijing 5
Paris 5
Princeton 5
Abuja 4
Chengdu 4
Esneux 4
Genoa 4
Milan 4
New York 4
Pune 4
Rome 4
Calgary 3
Hangzhou 3
Jiaxing 3
Madrid 3
Nanjing 3
Sigean 3
Wilmington 3
Bagnoli del Trigno 2
Bellingham 2
Brussels 2
Cambridge 2
Düsseldorf 2
Harvard 2
Hebei 2
Hoevenen 2
Istanbul 2
Jerusalem 2
Klaaswaal 2
Parma 2
San Diego 2
St Petersburg 2
Strijen 2
Vlaardingen 2
Woodbridge 2
Akron 1
Americana 1
Amsterdam 1
Ankara 1
Ann Arbor 1
Arau 1
Ashiharacho 1
Bacoli 1
Bacoor 1
Bangalore 1
Boston 1
Chandigarh 1
Changsha 1
Cipolletti 1
Cluj-napoca 1
Deposit 1
Duncan 1
El Fuerte 1
Fremont 1
Frosinone 1
Gainesville 1
Guiyang 1
Harbin 1
Hayward 1
Hefei 1
Helsinki 1
Homer 1
Homps 1
Honolulu 1
Hyderabad 1
Isfahan 1
Jacksonville 1
Kagoshima 1
Kelseyville 1
Lagos 1
Lappeenranta 1
London 1
Los Angeles 1
Lyon 1
Macerata 1
Moncalieri 1
Nanchang 1
Nonette 1
Norwalk 1
Oslo 1
Padova 1
Pittsburgh 1
Plainville 1
Prilep 1
Riverton 1
Royal Leamington Spa 1
San Jose 1
Totale 311
Nome #
The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer 247
Characteristics and outcome of BRCA mutated epithelial ovarian cancer patients in Italy: A retrospective multicenter study (MITO 21) 55
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies 54
Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study 36
The prognostic value of pain in castration-sensitive prostate cancer 26
Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society 18
Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study 14
Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21) 11
Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort 11
Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial 6
Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study 3
Totale 481
Categoria #
all - tutte 2.112
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.112


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 0 0 0 0 2 0 0 1 1 0 1 4
2020/202174 1 3 5 4 5 9 3 2 6 20 9 7
2021/2022100 4 11 2 11 6 5 3 5 14 3 18 18
2022/2023150 8 7 2 9 17 32 11 23 12 5 12 12
2023/2024141 20 16 6 13 7 18 3 16 7 15 6 14
2024/20257 7 0 0 0 0 0 0 0 0 0 0 0
Totale 481